LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.43 | 84.90 | 1325 | 3459 | 0.3830 | 0.6715 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.43 | 84.90 | 98 | 3459 | 0.0283 | 0.0272 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.43 | 84.90 | 1089 | 3459 | 0.3148 | 0.6113 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.14 | 84.90 | 1196 | 3682 | 0.3248 | 0.6264 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.14 | 84.90 | 1339 | 3682 | 0.3637 | 0.6606 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.14 | 84.90 | 106 | 3682 | 0.0288 | 0.0417 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.14 | 84.90 | 1094 | 3682 | 0.2971 | 0.6000 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.84 | 84.90 | 1262 | 4003 | 0.3153 | 0.6250 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.84 | 84.90 | 1418 | 4003 | 0.3542 | 0.6594 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.84 | 84.90 | 103 | 4003 | 0.0257 | 0.0354 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.84 | 84.90 | 1281 | 4003 | 0.3200 | 0.6294 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.55 | 84.90 | 1349 | 4287 | 0.3146 | 0.6303 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.55 | 84.90 | 1502 | 4287 | 0.3503 | 0.6616 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.55 | 84.90 | 118 | 4287 | 0.0275 | 0.0599 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.55 | 84.90 | 1162 | 4287 | 0.2710 | 0.5879 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.25 | 84.90 | 1440 | 4539 | 0.3172 | 0.6374 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.25 | 84.90 | 1547 | 4539 | 0.3408 | 0.6580 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.25 | 84.90 | 129 | 4539 | 0.0284 | 0.0756 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.25 | 84.90 | 1281 | 4539 | 0.2822 | 0.6044 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.95 | 84.90 | 1390 | 4952 | 0.2807 | 0.6105 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.95 | 84.90 | 1492 | 4952 | 0.3013 | 0.6301 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.95 | 84.90 | 133 | 4952 | 0.0269 | 0.0795 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.95 | 84.90 | 1335 | 4952 | 0.2696 | 0.5995 | MN20160318_Q02 | N22 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.65 | 84.90 | 1557 | 5328 | 0.2922 | 0.6276 | MN20160318_Q02 | G10 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.65 | 84.90 | 1637 | 5328 | 0.3072 | 0.6413 | MN20160318_Q02 | G10 |